|
Volumn 40, Issue 3, 2008, Pages 157-162
|
Specific VDAC inhibitors: Phosphorothioate oligonucleotides
|
Author keywords
Blocker; G3139; Mitochondria; Outer membrane; Randomer
|
Indexed keywords
ADENINE NUCLEOTIDE TRANSLOCASE;
CYCLOSPORIN A;
LIPOFECTIN;
OBLIMERSEN;
OLIGONUCLEOTIDE;
PHOSPHOROTHIOIC ACID DERIVATIVE;
PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE;
VOLTAGE DEPENDENT ANION CHANNEL;
ANTINEOPLASTIC ACTIVITY;
APOPTOSIS;
ARTICLE;
CHRONIC LYMPHATIC LEUKEMIA;
CLINICAL TRIAL;
CONCENTRATION RESPONSE;
CYTOSOL;
DRUG POTENCY;
DRUG PROTEIN BINDING;
DRUG SPECIFICITY;
DRUG STABILITY;
DRUG TARGETING;
HUMAN;
MELANOMA;
MEMBRANE PERMEABILITY;
MEMBRANE TRANSPORT;
MITOCHONDRIAL MEMBRANE;
MITOCHONDRIAL RESPIRATION;
MITOCHONDRION;
NONHUMAN;
OUTER MEMBRANE;
ANIMALS;
APOPTOSIS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
HUMANS;
MITOCHONDRIA;
MITOCHONDRIAL MEMBRANES;
MITOCHONDRIAL PROTEINS;
PHOSPHOROTHIOATE OLIGONUCLEOTIDES;
VOLTAGE-DEPENDENT ANION CHANNELS;
|
EID: 52449120644
PISSN: 0145479X
EISSN: 15736881
Source Type: Journal
DOI: 10.1007/s10863-008-9139-9 Document Type: Article |
Times cited : (25)
|
References (29)
|